⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9853 | 0.75 | — | — | |
| SCHEMBL1681247 | 0.72 | — | — | |
| SCHEMBL5146 | 0.72 | — | — | |
| SCHEMBL4646874 | 0.71 | — | — | |
| SCHEMBL26597347 | 0.71 | — | — | |
| SCHEMBL27437486 | 0.71 | — | — | |
| SCHEMBL2508334 | 0.71 | — | — | |
| SCHEMBL28100275 | 0.71 | — | — | |
| Bromide SCHEMBL28366176 | 0.71 | — | — | |
| SCHEMBL25917 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074891-A1 | BIFUNCTIONAL SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2025-03-06 | — | — | US | disclosed |
| WO-2024146559-A1 | PYRIDAZINONE HETEROCYCLIC COMPOUND MYOSIN II INHIBITOR AND USE THEREOF | 西藏海思科制药有限公司 | 2024-07-11 | — | — | WO | disclosed |
| CN-113454085-B | AZA heterobicyclic inhibitors of MAT2A and methods for treating cancer | 法国施维雅药厂 | 2024-05-07 | — | — | CN | disclosed |
| CN-117430588-A | Pyridazinone heterocyclic compound Myosin II inhibitor and application thereof | 西藏海思科制药有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-113474347-A | AZA heterobicyclic inhibitors of MAT2A and methods for treating cancer | 法国施维雅药厂 | 2021-10-01 | — | — | CN | disclosed |
| CN-113454085-A | AZA heterobicyclic inhibitors of MAT2A and methods for treating cancer | 法国施维雅药厂 | 2021-09-28 | — | — | CN | disclosed |
| US-9845278-B2 | Method for improving preservation stability of 2,2-difluoroacetaldehyde | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-12-19 | — | — | US | disclosed |
| US-9809534-B1 | Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof | ABBVIE INC. (US) | 2017-11-07 | — | — | US | disclosed |
| US-9765004-B2 | α,α-Difluoroacetaldehyde production method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-09-19 | — | — | US | disclosed |
| US-9765004-B2 | α,α-Difluoroacetaldehyde production method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-09-19 | — | — | US | disclosed |
| US-20120022264-A1 | METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2012-01-26 | — | — | US | disclosed |
| EP-2408746-A1 | METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | Bayer CropScience Aktiengesellschaft (DE) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010105747-A1 | METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010105747-A1 | METHOD FOR PRODUCING 2,2 DIFLUOROETHYLAMINE DERIVATIVES BY IMINE HYDROGENATION | BAYER CROPSCIENCE AG (DE) | 2010-09-23 | — | — | WO | disclosed |
| EP-2230231-A1 | Method for manufacturing 2,2-difluoroethylamine derivatives by imine hydrogenation | Bayer CropScience AG (DE) | 2010-09-22 | — | — | EP | disclosed |
| EP-2230231-A1 | Method for manufacturing 2,2-difluoroethylamine derivatives by imine hydrogenation | Bayer CropScience AG (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-20090185112-A1 | POLARIZING PLATE PROTECTIVE FILM AND METHOD FOR MANUFACTURING THE SAME, POLARIZING PLATE AND METHOD FOR MANUFACTURING THE SAME, AND LIQUID CRYSTAL DISPLAY DEVICE | KONICA MINOLTA OPTO, INC. (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-0335770-B1 | Novel fluorophosphonate nucleotide derivatives | MERRELL PHARMA INC (US) | 1997-01-15 | — | — | EP | disclosed |
| EP-0339161-A1 | Novel fluorophosphonate nucleotide derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-11-02 | — | — | EP | disclosed |
| EP-0335770-A2 | Novel fluorophosphonate nucleotide derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1989-10-04 | — | — | EP | disclosed |